Name | Number of supported studies | Average coverage | |
---|---|---|---|
neutrophil | 10 studies | 55% ± 21% | |
non-classical monocyte | 3 studies | 32% ± 18% |
Insufficient scRNA-seq data for expression of FCGR3B at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 99% | 2010.48 | 574 / 578 | 64% | 4.37 | 735 / 1155 |
liver | 81% | 221.53 | 182 / 226 | 23% | 2.16 | 95 / 406 |
spleen | 100% | 7338.19 | 241 / 241 | 0% | 0 | 0 / 0 |
kidney | 48% | 128.09 | 43 / 89 | 50% | 2.71 | 451 / 901 |
stomach | 27% | 127.85 | 97 / 359 | 64% | 4.95 | 184 / 286 |
peripheral blood | 81% | 72863.87 | 755 / 929 | 0% | 0 | 0 / 0 |
intestine | 22% | 59.66 | 210 / 966 | 58% | 4.27 | 305 / 527 |
bladder | 24% | 441.71 | 5 / 21 | 50% | 3.43 | 251 / 504 |
brain | 25% | 51.72 | 668 / 2642 | 39% | 1.65 | 277 / 705 |
esophagus | 19% | 54.80 | 275 / 1445 | 45% | 1.98 | 83 / 183 |
pancreas | 9% | 18.97 | 31 / 328 | 52% | 3.38 | 93 / 178 |
adipose | 61% | 373.82 | 739 / 1204 | 0% | 0 | 0 / 0 |
uterus | 25% | 76.42 | 42 / 170 | 36% | 2.03 | 164 / 459 |
skin | 37% | 137.76 | 675 / 1809 | 22% | 0.78 | 103 / 472 |
breast | 30% | 67.43 | 138 / 459 | 23% | 2.12 | 260 / 1118 |
heart | 53% | 158.58 | 458 / 861 | 0% | 0 | 0 / 0 |
prostate | 30% | 57.40 | 73 / 245 | 16% | 0.35 | 78 / 502 |
thymus | 35% | 79.93 | 229 / 653 | 7% | 0.22 | 45 / 605 |
tonsil | 0% | 0 | 0 / 0 | 40% | 1.45 | 18 / 45 |
adrenal gland | 16% | 19.65 | 40 / 258 | 23% | 1.23 | 52 / 230 |
ovary | 9% | 21.83 | 17 / 180 | 19% | 0.66 | 81 / 430 |
blood vessel | 25% | 86.76 | 335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 17% | 1.98 | 5 / 29 |
muscle | 13% | 20.60 | 106 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006955 | Biological process | immune response |
GO_0001788 | Biological process | antibody-dependent cellular cytotoxicity |
GO_0038094 | Biological process | Fc-gamma receptor signaling pathway |
GO_0007166 | Biological process | cell surface receptor signaling pathway |
GO_0030667 | Cellular component | secretory granule membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0009897 | Cellular component | external side of plasma membrane |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0019864 | Molecular function | IgG binding |
GO_0034235 | Molecular function | GPI anchor binding |
GO_0019770 | Molecular function | IgG receptor activity |
Gene name | FCGR3B |
Protein name | Low affinity immunoglobulin gamma Fc region receptor III-B (Fc-gamma RIII-beta) (CD16-I) (Fc-gamma RIII) (Fc-gamma RIIIb) (FcRIII) (FcRIIIb) (FcR-10) (IgG Fc receptor III-1) (CD antigen CD16b) Low affinity immunoglobulin gamma Fc region receptor III-A Fc gamma receptor IIIb Fc gamma receptor III-B |
Synonyms | IGFR3 FCGR3 FCG3 CD16B |
Description | FUNCTION: Receptor for the Fc region of immunoglobulins gamma. Low affinity receptor. Binds complexed or aggregated IgG and also monomeric IgG. Contrary to III-A, is not capable to mediate antibody-dependent cytotoxicity and phagocytosis. May serve as a trap for immune complexes in the peripheral circulation which does not activate neutrophils. |
Accessions | ENST00000367964.6 ENST00000534776.1 A0A3B3ISU3 O75015 A0A5A4UD02 H0Y4U3 ENST00000421702.4 E9PNY5 ENST00000650385.1 |